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A B S T R A C T
Aspartate kinase (AK) is an enzyme which is tightly regulated through feedback control and responsible
for the synthesis of 4-phospho-L-aspartate from L-aspartate. This intermediate step is at an important
branch point where one path leads to the synthesis of lysine and the other to threonine, methionine and
isoleucine. Concerted feedback inhibition of AK is mediated by threonine and lysine and varies between
the species. The crystal structure of biotechnologically important Clostridium acetobutylicum aspartate
kinase (CaAK; E.C. 2.7.2.4; Mw = 48,030 Da; 437aa; SwissProt: Q97MC0) has been determined to 3 Å
resolution. CaAK acquires a protein fold similar to the other known structures of AKs despite the low
sequence identity (<30%). It is composed of two domains: an N-terminal catalytic domain (kinase
domain) and a C-terminal regulatory domain further comprised of two small domains belonging to the
ACT domain family. Pairwise comparison of 12 molecules in the asymmetric unit helped to identify the
bending regions which are in the vicinity of ATP binding site involved in domain movements between the
catalytic and regulatory domains. All 12 CaAK molecules adopt fully open T-state conformation leading to
the formation of three tetramers unique among other similar AK structures. On the basis of comparative
structural analysis, we discuss tetramer formation based on the large conformational changes in the
catalytic domain associated with the lysine binding at the regulatory domains. The structure described
herein is homologous to a target in wide-spread pathogenic (toxin producing) bacteria such as
Clostridium tetani (64% sequence identity) suggesting the potential of the structure solved here to be
applied for modeling drug interactions. CaAK structure may serve as a guide to better understand and
engineer lysine biosynthesis for the biotechnology industry.
ã 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Among plant amino acid biosynthesis pathways, the aspartate-
derived amino acid pathway has received much attention by
researchers because of the nutritional importance [1]. This
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aspartate and therefore is commonly called aspartate-derived
amino acids (Scheme 1a) [2]. Since asp-derived pathway does not
exist in bacteria, fungi, humans and other animals, they depend on
plants as the source of these essential amino acids. The ﬁrst
enzyme of the pathway is aspartate kinase (AK; E.C. 2.7.2.4) is
leading to the synthesis of multiple end products and their
biosynthetic intermediates controlled by feedback inhibition. AK
catalyzes the ﬁrst step i.e., transfer of the g-phosphate group of
ATP to aspartate and responsible for the formation of aspartyl-4-
phosphate (Scheme 1b).
The aspartate kinase enzymes exhibit complex allosteric
regulation. For instance, in Arabidopsis thaliana which contains
ﬁve AKs, three of them are mono-functional AKs subjected toder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Scheme 1. a Schematic representation of the branched pathway in Clostridium acetobutylicum for synthesis of lysine, methionine, threonine and isoleucine from aspartate.
Arrows represent multiple enzymatic steps. Feedback inhibition by threonine and lysine on aspartate kinase was showed in gray lines. Scheme 1b reaction catalyzed by
aspartate kinase. Schematic diagram generated using the program ISIS/Draw [59].
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and the other two are bi-functional AKs conjugated with-
homoserine dehydrogenase (HSDH) subjected to the feedback
inhibition by threonine and leucine [3]. In Escherichia coli which
contains three AK isozymes (two bi-functional and one monofunc-
tional), however, only two of them are involved in allosteric control
[4]. Three isoforms of AKs are also found in Bacillus subtilis [5,6].
Simpler allosteric regulation also exists in some organisms;
Methanococcus jannashii and Thermus thermophilus contain only
one AK which synthesizes only threonine [7] whereas in
Synechocystis and Corynebacterium glutamicum the pathway leads
to the synthesis of both threonine and lysine [8,9]. Mycobacterium
tuberculosis exhibits a single isoform and potential feedback
inhibiton mechanisms are not known [10]. The evolution of
different types of AKs (monofunctional or bifunctional) and their
phylogenetic relationships were described recently [11]. The
allosteric regulation in this pathway, which involves not only
downstream metabolites in the aspartate-derived amino acids, but
also seemingly unrelated substances, provides precursors for the
biosynthesis of other essential plant metabolites. This suggests
that aspartate kinase is an important checkpoint for balancing the
relative ﬂux of different plant amino acid biosynthesis pathways
[1,12]. Several metabolic intermediates of this pathway play major
roles in quorum sensing [13,14], bacterial sporulation [15],
methylation reaction [16] and cell wall crosslinking [17]. For
example, an intermediate of lysine biosynthetic branch, meso-
diaminopimelate is also a component of the peptidoglycan which
is an essential component for cell wall synthesis. Interruption of
the production of lysine and cell wall formation, by inhibitingaspartate kinase activity, is well established [18]. Depending upon
the organism selected, metabolic branch point variation is
observed [19].
Clostridium acetobutylicum is widely used organism in bio-
technology industry, its genome has recently been sequenced and
analyzed, and a database of the predicted protein complement has
been published [20,21]. In view of its diversity and complexity in
the allosteric control in variety of species, AK from C. acetobuty-
licum (CaAK) was targeted for structure function analysis. CaAK
gene encodes a protein of 437amino acids with a predicted
molecular mass of 48,030 Da (SwissProt:Q97MC0; PSI TargetTrack:
NYSGXRC-6204b). An enzyme CaAK is homologous to the
pathogenic (toxin producing) bacteria Clostridium tetani aspartate
kinase (CtAK; spQ891L5; 64% identity) and Clostridium perfringens
aspartate kinase (CpAK; spQ8XJS6; 25% identity) suggesting the
potential to be a possible drug target for these organisms (Fig. 1).
Further, AKs are key enzymes controlling the biosynthesis of
industrially important family of amino acids and deciphering the
mechanism of end-product feedback inhibition of these allosteric
enzymes is an essential issue for the development of highly
efﬁcient microbial strains for bio-production. Also, AKs has a very
important biotechnological potential as it can limit the content of
an essential amino acid (lysine) in cereals [22]. Sequence analysis
of CaAK suggests that it comprised of two domains, namely,
N-terminal conserved amino acid kinase domain (Pfam PF00696)
considered as catalytic domain indicates that CaAK belongs to
amino acid kinase family. This domain is further divided into two
lobes, the N-lobe making up the Asp-binding site and the C-lobe
providing a nucleotide-binding pocket for ATP. A second domain of
Fig. 1. Multiple sequence alignment against homologs. Aspartate kinases are identiﬁed as their abbreviation: CaAK (sp Q97MC0; C. acetobutyliucm); CtAK (sp Q891L5; C.
tetani; 64.8% identity); CpAK (sp Q8XJS6; C. perfringens; 25.6% identity); EcAKIII (sp P08660; E. coli; 25.9% identity), AtAK (sp Q9LYU8; A. thaliana; 28.4% identity) and MjAK (sp
Q57991; M. jannashii ; 25.4% identity). Conservation of residues are shown in four layers, such as, fully (100%), highly (80%), partially (60%) and none with foreground shades in
blue, green, pink and none colour respectively. The residues which are conserved in dimer and tetramer interaction are shown in blue and red letters at the top of the
numbering line respectively. The alignment was generated using the program ClustalW [60]. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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small domains belonging to the ACT domain family (Pfam
PF01842). ACT domains are ligand-binding domains that are
found in a wide variety of regulated proteins [23,24].
The structural and biochemical studies of AKs from different
organisms highlighted the molecular basis of the diversity of
allosteric regulation and the many structural faces of AKs sensitive
to the concerted inhibition [19,25]. Based on the crystallographic
structures AKs are categorized into three classes. Class I contains
the homo-dimeric enzymes from E. coli, Methanococcus jannaschii
and A. thaliana with one catalytic domain and two ACT domains per
monomer [26–28]. The dimerization is mediated by the associa-
tion of the ACT domains. Class II contains to the hetero-tetrameric
enzyme from C. glutamicum with one catalytic domain and two
ACT domains per a-subunit and two ACT domains per b-subunit
[29]. The oligomerization involves strong association of the
catalytic domain of the a-subunits and the interaction of the
ACT domains of a and b-subunits. Class III contains the homo-
dimeric enzyme from Synechocystis with one catalytic domain and
four ACT domains per monomer [9]. In this case, dimerization only
involves the catalytic domain. However, there are many AKs from
whole genomic database, but minimal crystallographic and
biochemical data is available to demonstrate the regulatory
principles of structural allostery. Here we report the crystallo-
graphic analysis of AK from C. acetobutylicum to a resolution of
3.0 Å in order to deﬁne the relationship between the assembly of
AKs and the allosteric mechanism of AK, which may be relevant for
industrial uses such as the development of effective lysine
production strain.2. Results and discussion
2.1. Overall structure of CaAK
The structure of CaAK was determined to 3 Å resolution by
single wavelength anomalous dispersion (SAD) method. The
crystals belong to the monoclinic space group P21 and forming
a total of 576 kDa protein (12 monomers in asymmetric unit with
each 48 kDa) which posed the problem of solving the constellation
of 108 Se atoms (9 SeMet residues/monomer) in the asymmetric
unit. The anomalous differences for the SeMet peak data used
successfully to locate about 80% of Se atoms. The successful
substructure solution presented here adds to the database of
largest selenium substructures that has been determined to date
[30]. Although the diffraction limit of the CaAK crystals was
relatively low (3 Å resolution). However, the resolution was
compensated by the signiﬁcant level of non-crystallographic
symmetry (NCS) restraints, enabling reﬁnement of the structure.
The overall geometry of the model is of good quality, with 86% of
the residues in the most favored regions and 14% in allowed
regions of the Ramachandran map and model was reﬁned to an
R-factor of 20.7% (Rfree of 27.3%).
CaAK monomer belongs to the class I type AKs which consists of
one catalytic domain and two ACT domains (Fig. 1a) [25]. The
superposition of complete chain of A on the other 11 chains yields
root-mean-square deviation (r.m.s.d) between 0.68 Å and 1.36 Å,
indicating that all 12 chains in the asymmetric unit of the CaAK
crystal are similar. The superposition of CaAK dimer AB on the other
dimers CD, EF, GH, IJ and KL in the asymmetric unit yield r.m.s.d’s of
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biological unit of aspartate kinases is homodimeric which is formed
between identical ACT domains from two neighboring subunits
(Fig.1b). ACT1 domains from chain A and B are arranged side-by-side
with the creation of two equivalent effector binding sites at the
interface. Similarly, ACT2 of one monomer interacts with the ACT2 of
the other monomer. The homodimers are further associates into
CaAK tetramer (Fig. 1c). There were three tetramers of CaAK
observed in the asymmetric unit. A simultaneous least-squares
superposition of the tetramer ABCD on to EFGH and IJKL tetramers
results in alignment with r.m.s.d’s of 2.4 and 2.9 Å, respectively. The
three tetramers of CaAK comprise six homodimers which exhibits
essentially identical overall dimeric architecture.
The overall fold is similar to the other class I AKs although these
shares very low sequence identity. Speciﬁcally, Fig. 2 compares
E. coli aspartate kinase III (EcAkIII-PDB 2J0X and 2J0W with r.m.s.d
2.2 Å and 3.8 Å, respectively; 25.9% sequence identity) [26],
A. thaliana aspartate kinase (AtAK-PDB 2CDQ; rmsd 3.0 Å; 26%
sequence identity) [28], and M. jannaschii aspartate kinase (MjAK-
PDB 3C1N, 3C20 and 3C1M with rmsd 2.6 Å, 3.0 Å and 4.3 Å,
respectively; 27.9% sequence identity) [27]. The N-terminal
domain of CaAK is considered to be the catalytic domain (AKa-
residues 1–282) and belongs to the amino-acid kinase family [31]
with a conserved eight-stranded b-sheet sandwiched between
two layers of a-helices. The catalytic domain is further divided into
the N-terminal lobe (residues 1–200 shown in purple) and the
C-terminal lobe (residues 201–282 shown in brown color) [26–28].
The C-terminal domain is considered to be regulatory domain and
two perpendicular ACT domains (ACT1 and ACT2 shown in pink
and green respectively) having the architecture similar to the
known class I AK structures. Previously, the ACT domain has been
identiﬁed as modular regulatory unit associated with the control of
variety of metabolic processes [9,32–34]. ACT1 (residues 295–372)
has a babbab topology similar to the typical ACT domain and was
ﬁrst identiﬁed in the structure of 3-phosphoglycerate dehydroge-
nase (PGDH; PDB 1YGY) [35]. ACT2 made up of C-terminal residuesFig. 2. Structure of CaAK complexed with lysine. The N-lobe and C-lobe of catalytic
domain are shown in purple and brown respectively. The substrates (aspartate and
ADP) binding sites are shown. The regulatory domain contains ACT1 and ACT2 are
shown in pink and green respectively. The effector binding site bound to lysine is
represented in stick model with transparent surface. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)372–437 has the topology babba and another b strand (residues
283–295) located before the ACT1 to complete the ACT domain
architecture. This arrangement is ﬁrst identiﬁed in the AtAK [28].
The allosteric mechanisms associated with the ACT domains are
generally linked to ligand binding to these domains elicits
structural changes that alter the catalytic function at the active
site located at the other region of the enzyme [36].
2.2. T-state homodimeric architecture of CaAK
The active biological unit of aspartate kinases is homodimeric
which is formed between identical ACT domains from two
neighboring subunits. ACT1 domains from chain A and B are
arranged side-by-side with the creation of two equivalent effector
binding sites at the interface. Similarly, ACT2 of one monomer
interacts with the ACT2 of the other monomer. Thus, the entire
regulatory domain consists of the four ACT domains making the
core of 16 strands with eight-stranded antiparallel b-sheet with
four helices on each side. The homodimeric arrangement of CaAK
closely resembles the T-state conformation of the AK structures
(Fig. 3A and B). It was hypothesized from the crystal structures of
EcAKIII (PDB Ids 2J0X and 2J0W) that binding of lysine to the
enzyme induces the conformational transition from the R-state to
T-state (Fig. 3B and C). Close inspection of the electron density map
reveals that two Lys molecules are bound at the ACT1 dimer
interface of CaAK (Fig. 7A) similar to the other lysine bound AK
crystal structures further supporting a T-state conformation of our
Ca AK structure. Further, the mean solvent accessible surface area
(SASA) for the isolated Ca AK monomers and dimers are calculated
to be 20,227 and 36,571 Å2, respectively. The mean SASA between
monomers and dimers is approximately 3880.6 and 7761 Å2,
respectively. These values are about 3% less when compared to the
other structures of class I AKs (Table 3). The dimer interface
present in the CaAK is noteworthy for hydrophobic interactions
that stabilize the homodimer including the interactions with the
lysine bound between the ACT domains. The residues which are
involved in dimeric interactions are shown in blue letters at the top
of the sequence (Fig. 1). Dimerization of AK in solution has been
reported [26–28,37] and has been also identiﬁed in the crystal
state by X-ray crystallography. Further, nearly all class I AK crystal
structures bound to effector molecules have been crystallized as a
dimer of dimers. The tetramer interface is mainly mediated
through the catalytic domain which is apparent across a
crystallographic 2-fold axis of the T-state homodimeric CaAK.
Various solution studies were conducted to address the discrep-
ancy in the quaternary structure of AK which revealed that the
formation of the cooperative tetramer is possible upon effector
binding [25,38].
2.3. Domain motion in CaAK
Despite the fact that the enzyme had been crystallized in the
absence of lysine, the structure reveals lysine bound form of CaAK
which enable us to identify the key elements which are
responsible for the large conformational changes associated with
the inhibitor binding. The DynDom analysis clearly indentiﬁed the
bending residues at the domain crossover regions (D208–L213 and
E237–I250) in order to support the domain motion between the
regulatory and catalytic domains of CaAK (Fig. 4A and B). The
analysis provides the rotation angle of monomers B, D, E, I as 7.3;
8.2; 7.3 and 3.7, respectively whereas no rotational angle was
detected for the monomers C, F, G, H, J, K and L when monomer A
was used as the reference structure. Further rotational analysis on
all combinations of monomers showed the rotational angle and
the value lies between 4 to 8 between the monomers. The
domain reorientation is mainly controlled by interaction between
Fig. 3. Aspartate kinse homodimeric states: (A) lysine bound T-state homodimeric arrangement of CaAK. Two lysine molecules (shown as stick representation) bound
between the two ACT1 domains from different monomer (shown megenta and skyblue). ACT2 domains from different monomers (shown in green and pale yellow) stabilizing
the dimer structure and transmitting the lysine binding signal to the catalytic domain. (B) Lysine bound T-state homodimeric arrangement of EcAKIII homodimer (shown in
yellow, PDB 2J0X); (C) R-state homodimeric arrangement of EcAKIII homodimer (shown in yellow, PDB 2J0W). (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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catalytic domain and E303, L306, N308, V335, D336 and S337 of
regulatory domains. The varied interaction is induced by either
lysine binding at the homodimeric interface or nucleotide binding/
release at the domain crossover regions. In order to support thisobservation, the relative reorientation of the domains is observed
in different MjAK complex structures (PDB Ids 3C1N, 3C20 and
3C1M). The rotational angle varies between 6.3 and 18.9 and
demonstrates the inhibitor, substrate and cofactor binding to mjAK
induces the conformational changes between the domains. Both
Fig. 4. Domain motion in aspartate kinase: (A) superposition of T-state EcAKIII homodimer (shown in yellow, PDB 2J0X) on the CaAK homodimer represents the more open
conformation due to increased relative re-orientation of catalytic domains. (B) Zoom view of the domain crossover regions and corresponding residues. (For interpretation of
the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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(CaAK: E343–D348 and MjAK: S366–V370) and do not appear to
play a role in conformational arrangements. In contrast, the crystal
structures of EcAKIII solved in both R- and T-state conformation
(PDB Ids 2J0X and 2J0W) demonstrated the largest rotation
(36.3) between the catalytic and regulatory domain. The critical
latch loop (D354–T364) leading to the transition from R- to T-state
and tetramer formation that undergoes major rotational rear-
rangements. The latch loop is well conserved in the structure of
AtAK (D387–I397) appears to play a role in conformational
rearrangements and tetermer formation similar to EcAKIII. The
superposition of four ACT domains of CaAK dimer on the
corresponding four ACT domains of dimeric structures of EcAKIII
(PDB 2J0X and 2J0W with rmsd of 1.3 Å and 1.5 Å, respectively),
AtAK (PDB 2CDQ with rmsd of 4 Å), MjAK (PDB 3 C1 M, 3 C1 N and
3C20 with rmsd of 2 Å; 1.9 Å and 1.8 Å, respectively) revealed that
ACT domains adopt a similar conformation. However, the domain
reorientation is observed in comparison with EcAKIII, At AK and
MjAK homodimers. Fig. 3B represents the superposition ofregulatory domains of CaAK homodimer on the EcAKIII T-state
structure (2J0X). The regulatory domains were aligned with low
rmsd (1.3 Å). In contrast, the catalytic domains of monomer A and
B of CaAK were rotated outwards with an angle of 15.4 and 22.9
with respect to dimer of EcAKIII T-state structure (Fig. 4A and B).
This supports the observation that the increased open T-state
conformation which is mainly due to the catalytic domain
reorientation which is linked to the catalytic mechanism of the
enzyme.
2.4. Tetramer formation in CaAK
The rotational rearrangement of catalytic domains of CaAK
ultimately induced to form a compact tetramer (Fig. 5A) which is
unique among any other tetramer observed in class I AKs. Fig. 6
represents the tetrameric views observed in the structures of
EcAKIII, AtAK and MjAK. The various snapshots of AK tetramers
show the decrease in size of the central cavity due to an increase in
rotational angle between the catalytic domains leading to more
Fig. 5. Aspartate kinase Tetramer. (A) Cartoon representation of the compact
tetramer formed between the two homodimers of CaAK. Surface representation is
also shown. (B) Zoom view of the interaction of four helices of the ACT1-ACT1
domains from the different homodimers are shown.
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increased number of interactions with regulatory domain (ACT
domains – four helices each side – Fig. 5B) in addition to the
regular interactions at either side of the catalytic domains. The
residues which are involved in tetrameric formation are shown in
red letters at the top of the numbering line (Fig. 1). The central
cavity is completely closed in CaAK structure which increases in
tetrameric buried surface area (BSA). BSA is about 4–5% in all the
class I AKs whereas in the CaAK tetramer it is about 8% (Table 3).
The signiﬁcance of the dimer to tetramer transition observed in
CaAK structure is also valid biochemically. Firstly, despite the low
value of this interface, solution measurements indicate that this
binding afﬁnity is strong enough to sustain tetramer formation.
Secondly, given the fact that the similar tetrameric interactions
occur four times in different crystallographic environments
including in the structure of CaAK with different snapshots
supports that the tetramer formation is biochemically relavant
phenamenon (Fig. 6). Thirdly, the interactions obesrved between
the ACT domains (Fig. 5B) of CaAK homodimers were not obereved
in any known AK structures. Finally, the tetrameric view of the
EcAKIII represents the most open tetrameric form and the
structures MjAK (3 C1 M) and CaAK are the most compact
tetrameric structures. Fig. 6F represents the superposition of the
tetrameric views of MjAK on the CaAK (shown in pink) reveals thatCaAK tetramers are most compact ever observed and which is
unique among other tetrameric organization of the class I AK
structures. The transformation of the open form to the closed form
tetramer observed in class I AK structures provide the evidence
that they are genuine biochemical entities.
2.5. Network of residues involved in catalytic and regulatory roles
2.5.1. Lysine binding site
The crystallographic structures of AK’s reveal that the different
organizations in ACT domains lead to a great variety of control
allowing allosteric inhibition by lysine or threonine [9,28]. The
residues from monomer A (N308, G312, C314, F313, S333, G334,
G335, S336) and monomer B (S327, F328 and E329) are
interacting with lysine in the crystal structure of CaAK
(Fig. 7B). Lysine–protein interactions pattern more similar in
the lysine bound structures of EcAKIII (PDB 2J0X) and AtAK (PDB
2CDK) than the threonine bound structure MjAK (PDB ID 3C1N). In
the structure of EcAKIII, the residues M318, S321, G323, F324, L325,
T344, S345, G346 from monomer A and residues S338, V339, D340
from monomer B are involved in lysine binding (Fig. 7C). The
mutational analysis of EcAKIII detected two amino acid residue
regions (318–325 and 345–352) that may be important in feedback
inhibition in EcAKIII [39]. On comparison essential/conserved
residues between the structures of CaAK and EcAKIII reveals that
the residue C314 might play an important role in binding the lysine
in CaAK structure. Recently, in silico studies combined with
co-evolutionary analysis on EcAKIII further conﬁrmed the previous
studies and helped to identify the network of residues involved in
allosteric regulation [40].
2.5.2. Asp binding site
The multiple sequence alignment of CaAK against class I AKs
suggests that the catalytic activity and aspartate binding residues
are fully conserved. Previous site directed mutagenesis and
crystallographic studies of EcAKIII identiﬁed two residues, K8
and D202, that appear to play roles in the enzymatic activity while
residues E119 and R198 are involved in the binding of amino acid
substrate, having interactions with the a-NH3+ and a-COO
groups of aspartate, respectively [41]. Interestingly, the multiple
sequence alignment of CaAK on EcAKIII suggests that correspond-
ing residues K7 (K8 of AKIII), D188 (D202 of AKIII), E116 (E119 of
AKIII) and R184 (R198 of AKIII) are fully conserved (Fig. 1) in CaAK.
The aspartate binding environment of CaAK is homologous to
other class I AKs.
2.5.3. Nucleotide binding site
Most of the residues at the domain crossover regions (W208–
G213 and E237–I250) are also conserved (Fig. 4B). In the crystal
structure of MjAK, the residues D239 and R241 are involved in
binding to nucleotide. The sequence alignment shows that the
corresponding residues D216 and R218 are conserved in CaAK
(Fig. 1). In the structure of CaAK the residues at nucleotide binding
region shows disorder. The residues from Y239 to L245 are not
visible in the electron density map for the chains A, C, F, G, I, K and L
whereas for the chains B, D, H and J these residues are visible with
elevated temperature factors without the side chains for some of
the residues. This observation suggests that the nucleotide binding
to CaAK will be similar to that of MjAK. The main differences
between all class I AK structures are with relative orientation of the
sub-domains and variable length of the latch loop between the
catalytic and regulatory domains. The structural differences are
linked to differentiate the end-product (lysine/threonine) sensi-
tiveness of AKs [27].
Fig. 6. Aspartate kinase tetrameric states. (A) EcAKIII (PDB 2J0X), (B) AtAK (PDB 2CDQ), (C) MjAK (PDB 3C1N), (D) MjAK (PDB 3C20), (E) MjAK (PDB 3C20), (F) Superposition of
the most compact tetrameric forms are shown: MjAK (PDB 3C20) on the CaAK (shown in pink). (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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Aspartate kinase in an allosteric enzyme has a wide applications
in biotechnological industry and mainly responsible for the
biosynthesis of amino acids. The efﬁciency of biosynthesis is
largely depends upon quality of strains used in microbial
fermentation. The understanding of the metabolic pathways of
lysine biosynthesis and regulation through metabolic engineering
helps to the effective strain development. The enzymatic actionand mechanism of inhibition of aspartate kinase is well understood
through large number of crystallographic and biochemical
analysis. However, continued efforts have been made to under-
stand the mechanism and regulation of aspartate kinase from
suitable organism to deﬁne the successful construction of
industrially producing strains. In the aspartate kinase, the binding
of lysine to the regulatory domain triggers the structural
rearrangements for formation of tetrameriztion of the biological
homodimers (Fig. 5). Concurrently, the allosteric transition of the
Fig. 7. Lysine binding site: (A) electron density representation contoured at 1s level for the lysine molecules bound between the two ACT1 domains from different monomers.
(B, C) Zoom view of the lysine binding region in CaAK and EcAKIII (PDB 2J0X) structures (corresponding residues are labelled).
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Table 1
Crystallographic data-collection statistics.
X-ray source NSLS X29 Beamline
Wavelength (Å) 0.9792
Space Group P21
Cell parameters (Å, ) a = 109; b = 274.2, c = 114
a = 90, b = 113.7, g = 90
No. of molecules in an asymmetric unit 12
Resolution range (Å) 20–3.0
B-factor Wilson plot (Å2) 70
Mosaicity range () 0.6–0.9
Total Reﬂections 724, 519
Unique Reﬂections 217, 894
Completeness (%)a,b 89.9 (79.7)
Redundancy 3.0 (2.8)
Mean I/s (I) 14.0 (2.0)
Rmerge(%)b,c 8.5 (72.8)
SHELXDd: Data used (Å) 20–3.8
Correlation coefﬁcient CC all/weak 45.69/32.02
Combined ﬁgure of merit (CFOM) 60.1
PAT ﬁgure of merit (FOM) 2.94
Number of Se atoms located 92 out of 108
ADDSOLVE FOMd 0.33
RESOLVE FOM with 12-fold NCSd 0.53
a Data completeness treats Bijvoët mates independently.
b Statistics for the highest resolution bin (1.9–1.93 Å) are given in parentheses.
c R merge =
P
hkl
P
i | I(hkl)i |  < I(hkl) >|/
P
hkl
P
i< I(hkl)i >.
d Substructure determination parameters are from SHELXD, ADDSOLVE and
RESOLVE.
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and eventually loss of enzymatic activity. In CaAK, the mechanism
of inhibition follows the similar fashion when compare to the other
class I AK enzymes. Mainly, most of the structural elements which
are implicated in probing the catalytic, substrate-binding and
allosteric mechanisms are conserved. Secondly, the way of binding
of lysine molecules at the interface of the two ACT1 domains from
different monomers provides to identify the residues which are
implicated in lysine interactions. This structural observation can be
tested by studying inhibition proﬁle of lysine in CaAK. Further, site-
directed mutational analysis of these residues makes it possible to
engineer the lysine binding site. This eventually helps to
manipulating the biosynthesis of amino acid to increase the
amino acid content and nutritive value in crops. Recently, much
work has been done to metabolically engineered crops and grains
with enhanced amino acid levels [42,43]. Thirdly, the mechanism
of structural transition to tetramer assembly is similar way to the
other three different crystallographic environments. However, the
tetramer conﬁguration of CaAK is totally different than the other
known AK structures. The improved understanding plant amino
acid biosynthesis pathways potentially helps to design strategies
employed for metabolic engineering. Finally, most of the residues
which are implicated in probing the catalytic, substrate-binding
and allosteric mechanisms are also conserved in pathogenic CtAK
and CpAK. Therefore, the structure we reported here will provide
useful information for drug design targeting on pathogenic AKs.
3. Conclusion
AK is a key enzyme controlling the biosynthesis of lysine. The
allosteric regulation of AK represents a typical mechanism of
metabolic control of strong rigid node, i.e., node is tightly
controlled at one of its branches by a combination of feedback
control and enzyme activation by metabolites from a competing
branch. The speciﬁc enzyme (AK) is feedback inhibited by its end
product either by lysine or threonine and activated by metabolite
from a competing branch (Asp). The presence of lysine in the
structure of CaAK (despite lysine is not part of crystallization
buffer) speculate that CaAK is more sensitive to be inhibited by
lysine than the threonine. The crystal structure of CaAK provides a
unique view of compact cooperative tetrameric oligomers which
yield insights into the molecular determinants for catalytic and
regulatory roles of the widespread and biotechnologically impor-
tant aspartate kinase enzymes.
4. Materials and methods
4.1. Protein puriﬁcation and crystallization
Puriﬁed native and selenomethionine-substituted (SeMet)
CaAK protein was obtained from the New York SGX Research
Center for Structural Genomics (PSI TargetTrack: NYSGXRC-
6204b). The protein with selenomethionine labeling was
expressed in E. coli high yield (HY) media and puriﬁed by standard
NYSGXRC protocol [43–46]. The HY media is prepared using
following procedure. To a 2 L bafﬂed ﬂask containing 950 ml
autoclaved Milli-Q water add one packet of M9 salts, 10 mL of
mineral supplement, 1 mL of vitamin supplement, 1 mL of
antibiotic (kanamycin 30 mg/mL solution) and 10 mL 50%
glycerol. Mix ﬂask and allow salts to go in to solution before
using. Brieﬂy, a full-length cDNA fragment of aspartate kinase
(GenBank AE001437) was ampliﬁed by polymerase chain reaction
(PCR) from C. acetobutylicum (strain ATCC 824) genomic DNA using
forward (AAAATCGTAGTAACAAAGTTTGG) and reverse
(CATTAAATGCATTGTATATGGATTTAACAGC) primers. The PCR
product was cloned into a vector pET modiﬁed for topoisomerasedirected cloning (Invitrogen) and designed to express the protein
of interest followed by a C-terminal hexa-histidine tag then was
transformed into TOP10 cells. The resulting clone was grown by
adding 500 mL of Luria–Bertani (LB) medium containing 500 mL of
30 mg/mL kanamycin, 25 mL of 10% glucose, and a small amount of
transformed cell glycerol stock scraping to a 2 L bafﬂed ﬂask at
30 C with overnight shaking (250 rpm). 10 mL of the resulting
culture was added to each of six ﬂasks containing similar culture
medium for large scale expression. The cultures were subjected to
shaking under similar conditions until the OD595 reached to the
range of 0.8. The protein expression was induced by adding
200 mL of 1 M isopropyl-D-thiogalactopyronoside (IPTG). After
overnight vigorous shaking (250 rpm, 21 C), the cells were
pelleted by centrifugation (in 1 L spin bottles; at 6500 rpm for
10 min). The pellets were collected into 50 mL conical tubes and re-
suspended in a lysis buffer (35 mL/10 g), 50 mL of protease inhibitor
cocktail tablet (Sigma and 5 mL of benzonase (Novagen). The cells
were lysed by repeated sonication (with intervals of cooling)
followed by centrifugation (38,900 g for 30 min). The ﬁltrate was
then immobilized on Ni-NTA-agarose resin (Qiagen), placed on a
drip column and washed with 25 mL buffer-A (50 mM Tris–HCl pH
7.8, 500 mM NaCl, 10 mM imidazole, 10 mM methionine, and 10%
glycerol). The protein was eluted into an Amicon concentrator
(Millipore) with 15 mL of buffer-A containing 500 mM imidazole.
The eluted protein was concentrated to 6 mL and loaded onto a gel
ﬁltration column (Superdex 200, Pharmacia). The fractions were
pooled, concentrated to 13.5 mg/mL and stored in 10 mM hepes
pH7.5, 150 mM NaCl, 10 mM methionine, 5 mM dithiothreitol
(DTT), 10% glycerol. Similarly, seleno-methionine labeled protein
was produced, puriﬁed and concentrated to 9.3 mg/mL. The clone
is available through DNASU.org as CaCD00423555.
Initial crystallization screening was performed on both Native
and SeMet-labelled proteins using the Hampton index screen
(Hampton Research, CA, USA). Microcrystals were observed from
several conditions and optimization screens were applied adjacent
to condition #71 (25% PEG 3350 and 100 mM Tris pH 6.5, 200 mM
NaCl), which provided the best crystals. Fan shaped crystals were
obtained for SeMet-labelled protein in an optimized condition
containing 13% PEG 3350 and 100 mM Tris HCl pH 6.5. Droplets
comprising 1.3 mL of protein plus 1.3 mL reservoir solution was
Table 2
Reﬁnement and ramachandran plot statistics.
Resolution range (Å) 20–3
Reﬂections used for reﬁnement (all) 104, 822
Reﬂections used for Rfree 5511
Rcryst(%)a 20.6
Rfree (%) 27.3
r.m.s.d. bond lengths (Å) 0.006
r.m.s.d. bond angles () 1.057
Favored region (%) 86 (3964)
Additional allowed region (% and number of residues) 14 (645)
Generously allowed regions (% and number of residues) 0.0
Outliers (%) 0.0
a Rcryst =
P
hkl || Fo(hkl )|  k | Fc(hkl )||/
P
hkl | Fo(hkl )|, where Fo and Fc are observed
and calculated structure factors.
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further work including crystallization trials with different
additives and streak seeding methods were undertaken with the
aim of obtaining better quality crystals. However, none of these
trials improved the crystal quality.
4.2. X-ray data collection and processing
The freshly prepared crystals were very fragile and became
rubbery after several days. These crystals diffracted poorly (to 4 Å
resolution) at beamline X3A and at 3.6 Å resolution at beamline
X29 of the national synchrotron light source (NSLS), Brookhaven
National Laboratory, New York. Optimization of cryo-protection
conditions helped in improving the diffraction properties of these
crystals and an X-ray dataset collected to 3.0 Å resolution at the
X29 beamline. Prior to data collection, a large crystal with a
maximum dimension was placed into mother liquor containing
10%, 20% and 30% glycerol for 10–15 s intervals, followed by
immediate ﬂash cooling to 100 K in a liquid nitrogen stream.
Single-wavelength anomalous dispersion (SAD) data wereTable 3
Surface area composition between the class I ak structures.
Enzyme
(PDB)
chains
Tetramer
surface area
(buried area)
Dimer
surface area
(buried area)
Monomer
surface area
(buried area)
Homodimeric interfa
Area % of surf
CaAK
(3TVI)
ABCD
70,000
(10,830)
36,390
(4020)
19,906.0 (2702.3) 2020.2 19 
20,510.1 (2704.2)
36,370
(4040)
20,267.0 (2752.7) 2011.3 19 
20,147.9 (2671.6)
CaAK
(3TVI)
EFGH
69,400 (11,060) 36,230 (3710) 20,103.7 (2712.0) 1853.7 17 
20,415.3 (2751.9)
36,940
(3580)
20,385.9 (2845.7) 1788.6 16 
19,550.4 (2748.6)
CaAK
(3TVI)
IJKL
70,629
(10,810)
37,020
(4010)
20,158.3 (2718.3) 2005.6 19 
20,251.1 (2644.6)
36,480
(3920)
20,698 (2744.9) 1962.4 18 
20,333.8 (2704.2)
MjAK
(3C1M)
ABCD
68,760
(13,490)
35,390
(5710)
20,689.9 (3382.5) 2856.3 21 
20,458.5 (3349.9)
35,460
(5690)
20,576.3 (3394.8) 2844.0 21 
20,524.9 (3362.9)
MjAK
(3C1N)
ABCD
70,860.9
(13,737.9)
36,010
(5810)
20,954.7 (3434.8) 2934.7 21 
20,867.5 (3404.9)
36,910
(5870)
21,120.1 (3434.1) 2905.4 21 
21,656.5 (3464.1)
MjAK
(3C20)
AB
69,814.8
(14,708.8)
35,900
(6360)
21,190.7 (3686.7) 3178.9 21 
21,071.1 (3667.7)
EcAK
(2J0X)
AB
67,320
(13,500.7)
34,800
(5610)
20,154.2 (3375.2) 2804 21 
20,254.7 (3375.2)
AtAK
(2CDQ)
AB
74,060
(13,990)
38,070
(5960)
21,969.6 (3497.7) 2979.2 21 
22,054.9 (3496.4)collected at the Se peak wavelength (0.9792 Å). The radiation
damage affected the quality of dataset collected at inﬂection and
remote wavelengths. The data were integrated with the program
HKL2000 and scaled with SCALEPACK [47]. Data collection
statistics are shown in Table 1.
4.3. Structure determination and reﬁnement
The crystals belong to the monoclinic space group P21 with
unit cell parameters a = 109 Å, b = 274.2 Å, c = 114 Å, b = 113.7. The
calculation of the Matthew's coefﬁcient based on the molecular
weight of 48,030 Da results in a VM of 2.7 Å3Da1 and a solvent
content of 54%, which corresponds to the presence of twelve
molecules in the asymmetric unit [48]. The anomalous differences
for the peak data were used to successfully locate 87 out of 108
selenium anomalous scatterers with the structure solving package
SHELXD [49]. The correlation coefﬁcient, CC, was all/weak: 45.69/
32.02 and Patterson ﬁgure of merit, PATFOM: 2.94. The selenium
sites were reﬁned along with additional 5 selenium sites identiﬁed
and initial phases were calculated to overall ﬁgure of merit of 0.33
with the program ADDSOLVE [50]. Further, phases were improved
to a ﬁgure of merit of 0.53 using solvent ﬂattening and twelve-fold
non-crystallographic symmetric averaging (NCS) in RESOLVE [51]
which yielded a partial model. The electron density map was
further improved by using single wavelength (Se peak) data as the
starting point in the MRSAD anomalous dispersion protocol of the
auto-rickshaw software pipeline which improved the model
substantially [52]. Several rounds of manual model building with
Coot [53] and reﬁnement with the program REFMAC5 [54,55] were
carried out. The ﬁnal model (R = 0.207, Rfree = 0.273) contains 5352
residues from 12 molecules in asymmetric unit (446aa  12mols)
along with six lysine and seven aspartate molecules. The model
quality was monitored using PROCHECK [56]. The coordinates and
structure factors were deposited in the RCSB Protein Data Bankce area Same side monomers interface 1 Opposite sidemonomers interface 2
ace Area % of surface Area % of surface
558.1 5 174.4 2
516.6 5 134.8 1
632.6 6 359.3 3%
564.1 5 330.7 3
546.3 5 209.5 2
529.9 5 152.2 2
538.4 4 None None
505.8 4 None None
529.4 4 None None
499.4 4 None None
498.3 3 None None
571.1 4 None None
518.8 4 None None
84 B.A. Manjasetty et al. / Biotechnology Reports 3 (2014) 73–85under accession code 3TVI. Tables 1 and 2 details our data
collection and reﬁnement statistics. Structural presentation was
generated using the program PyMol. The solvent-accessible
surface of monomers, dimer and tetramers as well as their
interacting interface was analyzed by PISA server [57]. Protein
domain motions were analyzed by using the DynDom server [58].
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